[Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].

Vorob'eva, N M; Panchenko, E P; Dobrovol'skii, A B; Titaeva, E V; Khasanova, Z B; Konovalova, N V; Postnov, A Iu; Kirienko, A I

Vorob'eva, N M; Panchenko, E P; Dobrovol'skii, A B; Titaeva, E V; Khasanova, Z B; Konovalova, N V; Postnov, A Iu; Kirienko, A I.

Ter Arkh ; 83(6): 59-65, 2011.

Article in Ru | MEDLINE | ID: mdl-21786578

Subject(s)

Anticoagulants/adverse effects; Aryl Hydrocarbon Hydroxylases/genetics; Hemorrhage/genetics; Mixed Function Oxygenases/genetics; Venous Thromboembolism/drug therapy; Warfarin/adverse effects; Adolescent; Adult; Aged; Anticoagulants/therapeutic use; Cytochrome P-450 CYP2C9; Female; Hemorrhage/chemically induced; Hemorrhage/epidemiology; Humans; Male; Middle Aged; Moscow/epidemiology; Polymorphism, Genetic; Vitamin K Epoxide Reductases; Warfarin/therapeutic use; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Warfarin / Aryl Hydrocarbon Hydroxylases / Venous Thromboembolism / Hemorrhage / Mixed Function Oxygenases / Anticoagulants Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: Ru Journal: Ter Arkh Year: 2011 Type: Article

Search on Google

XML

PubMed Links